Results 271 to 280 of about 262,635 (315)
Some of the next articles are maybe not open access.
Clinics in Liver Disease, 2012
The management of chronic hepatitis B virus (HBV) infection requires understanding the natural history of the disease as well as the risks, benefits, and limitations of the therapeutic options. This article covers the principles governing when to start antiviral therapy, discusses recent advances using hepatitis B surface antigen quantification to ...
Robert G. Gish, Alexander Kuo
openaire +3 more sources
The management of chronic hepatitis B virus (HBV) infection requires understanding the natural history of the disease as well as the risks, benefits, and limitations of the therapeutic options. This article covers the principles governing when to start antiviral therapy, discusses recent advances using hepatitis B surface antigen quantification to ...
Robert G. Gish, Alexander Kuo
openaire +3 more sources
Management of Chronic Hepatitis B
European Journal of Gastroenterology & Hepatology, 2011Chronic hepatitis B affects 400 million people worldwide. The criteria for initiating and stopping treatment are still under debate in spite of well-established agents for its treatment.
Lai, CL, Yuen, MF
openaire +6 more sources
Current Opinion in Gastroenterology, 2011
We review here new developments in chronic hepatitis B (CHB) treatment, based on review of published articles between December 2009 and November 2010.It is estimated that two-thirds of US CHB patients have not been identified, evaluated and appropriately treated, largely due to lack of knowledge and awareness of CHB among medical professionals and at ...
Hejun Yuan, William M. Lee
openaire +3 more sources
We review here new developments in chronic hepatitis B (CHB) treatment, based on review of published articles between December 2009 and November 2010.It is estimated that two-thirds of US CHB patients have not been identified, evaluated and appropriately treated, largely due to lack of knowledge and awareness of CHB among medical professionals and at ...
Hejun Yuan, William M. Lee
openaire +3 more sources
Management of chronic hepatitis B
Gastroenterology Clinics of North America, 2004Chronic hepatitis B (CHB) is a major worldwide cause of chronic liver disease and a significant public health issue. Three predominant clinical presentations are recognized: hepatitis B e antigen(HBeAg) or typical CHB, HBeAg-negative or atypical CHB, and inactive CHB.
Marc G. Ghany, Edward Doo
openaire +3 more sources
Treatment of Chronic Hepatitis B
Current Pharmaceutical Design, 2002Infection with the hepatitis B virus has switched over the last 20 years from the classical HBeAg positive serologic pattern to a HBeAg negative form that is linked, in the Mediterranean basin, with the epidemiologic replacement of the causative wild-type of virus B with mutant variants, whereby mutations in the core-promoter and in the pre-core region
M Rizzetto, M Lagget
openaire +3 more sources
Pathology of Chronic Hepatitis B and Chronic Hepatitis C
Clinics in Liver Disease, 2010Histologic evaluation of the liver is a major component in the medical management and treatment algorithm of patients with chronic hepatitis B (HBV) and chronic hepatitis C (HCV). Liver biopsy in these patients remains the gold standard, and decisions on treatment are often predicated on the degree of damage and stage of fibrosis. This article outlines
openaire +3 more sources
2021
Hepatitis B is a DNA virus (HBV) that causes an acute and chronic infection. The HBV is transmitted vertically from mother to child, from child to child, via sexual contacts, and through percutaneous exposure to blood or other infectious body fluids. Vaccination is fundamental in the prevention of HBV infection.
openaire +2 more sources
Hepatitis B is a DNA virus (HBV) that causes an acute and chronic infection. The HBV is transmitted vertically from mother to child, from child to child, via sexual contacts, and through percutaneous exposure to blood or other infectious body fluids. Vaccination is fundamental in the prevention of HBV infection.
openaire +2 more sources
2016
A 45-year-old male Chinese university lecturer presented to his GP with malaise and dark urine. He was referred to the local infectious diseases clinic, and blood tests were as follows:
N. Hansi +2 more
openaire +2 more sources
A 45-year-old male Chinese university lecturer presented to his GP with malaise and dark urine. He was referred to the local infectious diseases clinic, and blood tests were as follows:
N. Hansi +2 more
openaire +2 more sources
2018
Hepatitis B (HBV) is a viral infection of the liver and a common cause of chronic liver disease worldwide. An estimated 240 million people are affected by chronic hepatitis B (CHB) infection globally. In the United States, 850,000 to 2.2 million are estimated to be living with HBV.
Lindsay Meurer, Anthony B. Post
openaire +2 more sources
Hepatitis B (HBV) is a viral infection of the liver and a common cause of chronic liver disease worldwide. An estimated 240 million people are affected by chronic hepatitis B (CHB) infection globally. In the United States, 850,000 to 2.2 million are estimated to be living with HBV.
Lindsay Meurer, Anthony B. Post
openaire +2 more sources
New England Journal of Medicine, 1990
Chronic hepatitis B is said to affect at least 5 percent of the world's population and to be the chief cause of cirrhosis and hepatocellular carcinoma.1 The World Health Organization lists hepatiti...
openaire +2 more sources
Chronic hepatitis B is said to affect at least 5 percent of the world's population and to be the chief cause of cirrhosis and hepatocellular carcinoma.1 The World Health Organization lists hepatiti...
openaire +2 more sources